Mediation analysis of the alcohol‐postmenopausal breast cancer relationship by sex hormones in the EPIC cohort
Alcohol consumption is associated with higher risk of breast cancer (BC); however, the biological mechanisms underlying this association are not fully elucidated, particularly the extent to which this relationship is mediated by sex hormone levels. Circulating concentrations of estradiol, testostero...
Saved in:
Published in | International journal of cancer Vol. 146; no. 3; pp. 759 - 768 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.02.2020
Wiley Subscription Services, Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Alcohol consumption is associated with higher risk of breast cancer (BC); however, the biological mechanisms underlying this association are not fully elucidated, particularly the extent to which this relationship is mediated by sex hormone levels. Circulating concentrations of estradiol, testosterone, their free fractions and sex‐hormone binding globulin (SHBG), were examined in 430 incident BC cases and 645 matched controls among alcohol‐consuming postmenopausal women nested within the European Prospective Investigation into Cancer and Nutrition. Mediation analysis was applied to assess whether individual hormone levels mediated the relationship between alcohol intake and BC risk. An alcohol‐related hormonal signature, obtained by partial least square (PLS) regression, was evaluated as a potential mediator. Total (TE), natural direct and natural indirect effects (NIE) were estimated. Alcohol intake was positively associated with overall BC risk and specifically with estrogen receptor‐positive tumors with respectively TE = 1.17(95%CI: 1.01,1.35) and 1.36(1.08,1.70) for a 1‐standard deviation (1‐SD) increase of intake. There was no evidence of mediation by sex steroids or SHBG separately except for a weak indirect effect through free estradiol where NIE = 1.03(1.00,1.06). However, an alcohol‐related hormonal signature negatively associated with SHBG and positively with estradiol and testosterone was associated with BC risk (odds ratio [OR] = 1.25 [1.07,1.47]) for a 1‐SD higher PLS score, and had a statistically significant NIE accounting for a mediated proportion of 24%. There was limited evidence of mediation of the alcohol‐BC association by individual sex hormones. However, a hormonal signature, reflecting lower levels of SHBG and higher levels of sex steroids, mediated a substantial proportion of the association.
What's new?
Alcohol consumption is associated with an increased risk of breast cancer (BC). However, the mechanisms underlying this association are not yet fully understood. For example, do sex‐hormone levels play a role? In this study, the authors assessed a number of alcohol‐related hormonal signatures. They found that lower levels of sex‐hormone binding globulin (SHBG), combined with higher levels of sex steroids, mediate a substantial proportion of the observed alcohol‐BC association. It is likely that the mechanism involves the interplay of multiple hormones, rather than the action of individual hormones. |
---|---|
AbstractList | Alcohol consumption is associated with higher risk of breast cancer (BC); however, the biological mechanisms underlying this association are not fully elucidated, particularly the extent to which this relationship is mediated by sex hormone levels. Circulating concentrations of estradiol, testosterone, their free fractions and sex‐hormone binding globulin (SHBG), were examined in 430 incident BC cases and 645 matched controls among alcohol‐consuming postmenopausal women nested within the European Prospective Investigation into Cancer and Nutrition. Mediation analysis was applied to assess whether individual hormone levels mediated the relationship between alcohol intake and BC risk. An alcohol‐related hormonal signature, obtained by partial least square (PLS) regression, was evaluated as a potential mediator. Total (TE), natural direct and natural indirect effects (NIE) were estimated. Alcohol intake was positively associated with overall BC risk and specifically with estrogen receptor‐positive tumors with respectively TE = 1.17(95%CI: 1.01,1.35) and 1.36(1.08,1.70) for a 1‐standard deviation (1‐SD) increase of intake. There was no evidence of mediation by sex steroids or SHBG separately except for a weak indirect effect through free estradiol where NIE = 1.03(1.00,1.06). However, an alcohol‐related hormonal signature negatively associated with SHBG and positively with estradiol and testosterone was associated with BC risk (odds ratio [OR] = 1.25 [1.07,1.47]) for a 1‐SD higher PLS score, and had a statistically significant NIE accounting for a mediated proportion of 24%. There was limited evidence of mediation of the alcohol‐BC association by individual sex hormones. However, a hormonal signature, reflecting lower levels of SHBG and higher levels of sex steroids, mediated a substantial proportion of the association. Alcohol consumption is associated with higher risk of breast cancer (BC); however, the biological mechanisms underlying this association are not fully elucidated, particularly the extent to which this relationship is mediated by sex hormone levels. Circulating concentrations of estradiol, testosterone, their free fractions and sex-hormone binding globulin (SHBG), were examined in 430 incident BC cases and 645 matched controls among alcohol-consuming postmenopausal women nested within the European Prospective Investigation into Cancer and Nutrition. Mediation analysis was applied to assess whether individual hormone levels mediated the relationship between alcohol intake and BC risk. An alcohol-related hormonal signature, obtained by partial least square (PLS) regression, was evaluated as a potential mediator. Total (TE), natural direct and natural indirect effects (NIE) were estimated. Alcohol intake was positively associated with overall BC risk and specifically with estrogen receptor-positive tumors with respectively TE = 1.17(95%CI: 1.01,1.35) and 1.36(1.08,1.70) for a 1-standard deviation (1-SD) increase of intake. There was no evidence of mediation by sex steroids or SHBG separately except for a weak indirect effect through free estradiol where NIE = 1.03(1.00,1.06). However, an alcohol-related hormonal signature negatively associated with SHBG and positively with estradiol and testosterone was associated with BC risk (odds ratio [OR] = 1.25 [1.07,1.47]) for a 1-SD higher PLS score, and had a statistically significant NIE accounting for a mediated proportion of 24%. There was limited evidence of mediation of the alcohol-BC association by individual sex hormones. However, a hormonal signature, reflecting lower levels of SHBG and higher levels of sex steroids, mediated a substantial proportion of the association.Alcohol consumption is associated with higher risk of breast cancer (BC); however, the biological mechanisms underlying this association are not fully elucidated, particularly the extent to which this relationship is mediated by sex hormone levels. Circulating concentrations of estradiol, testosterone, their free fractions and sex-hormone binding globulin (SHBG), were examined in 430 incident BC cases and 645 matched controls among alcohol-consuming postmenopausal women nested within the European Prospective Investigation into Cancer and Nutrition. Mediation analysis was applied to assess whether individual hormone levels mediated the relationship between alcohol intake and BC risk. An alcohol-related hormonal signature, obtained by partial least square (PLS) regression, was evaluated as a potential mediator. Total (TE), natural direct and natural indirect effects (NIE) were estimated. Alcohol intake was positively associated with overall BC risk and specifically with estrogen receptor-positive tumors with respectively TE = 1.17(95%CI: 1.01,1.35) and 1.36(1.08,1.70) for a 1-standard deviation (1-SD) increase of intake. There was no evidence of mediation by sex steroids or SHBG separately except for a weak indirect effect through free estradiol where NIE = 1.03(1.00,1.06). However, an alcohol-related hormonal signature negatively associated with SHBG and positively with estradiol and testosterone was associated with BC risk (odds ratio [OR] = 1.25 [1.07,1.47]) for a 1-SD higher PLS score, and had a statistically significant NIE accounting for a mediated proportion of 24%. There was limited evidence of mediation of the alcohol-BC association by individual sex hormones. However, a hormonal signature, reflecting lower levels of SHBG and higher levels of sex steroids, mediated a substantial proportion of the association. Alcohol consumption is associated with higher risk of breast cancer (BC); however, the biological mechanisms underlying this association are not fully elucidated, particularly the extent to which this relationship is mediated by sex hormone levels. Circulating concentrations of estradiol, testosterone, their free fractions and sex-hormone binding globulin (SHBG), were examined in 430 incident BC cases and 645 matched controls among alcohol-consuming postmenopausal women nested within the European Prospective Investigation into Cancer and Nutrition. Mediation analysis was applied to assess whether individual hormone levels mediated the relationship between alcohol intake and BC risk. An alcohol-related hormonal signature, obtained by Partial Least Square (PLS) regression, was evaluated as a potential mediator. Total (TE), natural direct (NDE) and natural indirect effects (NIE) were estimated. Alcohol intake was positively associated with overall BC risk and specifically with estrogen receptor positive tumours with respectively TE=1.17(95%CI: 1.01,1.35) and 1.36(1.08,1.70) for a 1-SD deviation increase of intake. There was no evidence of mediation by sex steroids or SHBG separately except for a weak indirect effect through free estradiol where NIE=1.03(1.00,1.06). However, an alcohol-related hormonal signature negatively associated with SHBG and positively with estradiol and testosterone, was associated with BC risk (OR=1.25 (1.07,1.47)) for a 1-SD higher PLS score, and had a statistically significant NIE accounting for a mediated proportion of 24%. There was limited evidence of mediation of the alcohol-BC association by individual sex hormones. However, a hormonal signature, reflecting lower levels of SHBG and higher levels of sex steroids, mediated a substantial proportion of the association. Alcohol consumption is associated with higher risk of breast cancer (BC); however, the biological mechanisms underlying this association are not fully elucidated, particularly the extent to which this relationship is mediated by sex hormone levels. Circulating concentrations of estradiol, testosterone, their free fractions and sex‐hormone binding globulin (SHBG), were examined in 430 incident BC cases and 645 matched controls among alcohol‐consuming postmenopausal women nested within the European Prospective Investigation into Cancer and Nutrition. Mediation analysis was applied to assess whether individual hormone levels mediated the relationship between alcohol intake and BC risk. An alcohol‐related hormonal signature, obtained by partial least square (PLS) regression, was evaluated as a potential mediator. Total (TE), natural direct and natural indirect effects (NIE) were estimated. Alcohol intake was positively associated with overall BC risk and specifically with estrogen receptor‐positive tumors with respectively TE = 1.17(95%CI: 1.01,1.35) and 1.36(1.08,1.70) for a 1‐standard deviation (1‐SD) increase of intake. There was no evidence of mediation by sex steroids or SHBG separately except for a weak indirect effect through free estradiol where NIE = 1.03(1.00,1.06). However, an alcohol‐related hormonal signature negatively associated with SHBG and positively with estradiol and testosterone was associated with BC risk (odds ratio [OR] = 1.25 [1.07,1.47]) for a 1‐SD higher PLS score, and had a statistically significant NIE accounting for a mediated proportion of 24%. There was limited evidence of mediation of the alcohol‐BC association by individual sex hormones. However, a hormonal signature, reflecting lower levels of SHBG and higher levels of sex steroids, mediated a substantial proportion of the association. What's new? Alcohol consumption is associated with an increased risk of breast cancer (BC). However, the mechanisms underlying this association are not yet fully understood. For example, do sex‐hormone levels play a role? In this study, the authors assessed a number of alcohol‐related hormonal signatures. They found that lower levels of sex‐hormone binding globulin (SHBG), combined with higher levels of sex steroids, mediate a substantial proportion of the observed alcohol‐BC association. It is likely that the mechanism involves the interplay of multiple hormones, rather than the action of individual hormones. |
Author | Chirlaque, María‐Dolores Gurrea, Aurelio Barricarte Ferrari, Pietro Bonet, Catalina Viallon, Vivian Onland‐Moret, Charlotte Sánchez Pérez, María José Dashti, S. Ghazaleh Christakoudi, Sofia Kvaskoff, Marina Fournier, Agnès Gils, Carla H. Cervenka, Iris Bueno de Mesquita, H. Bas Tsilidis, Kostas Karakatsani, Anna Assi, Nada Trichopoulou, Antonia Amiano Etxezarreta, Pilar Overvad, Kim Turzanski‐Fortner, Renée Palli, Domenico Tjønneland, Anne Key, Tim Riboli, Elio Ricceri, Fulvio Tumino, Rosario Merino, Susana Grioni, Sara Dossus, Laure Bergmann, Manuela Rinaldi, Sabina Martimianaki, Georgia Boeing, Heiner Ellingjord‐Dale, Merete Kaaks, Rudolf Panico, Salvatore Gunter, Marc J |
AuthorAffiliation | 8 Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy 30 The Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark 15 Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria, IBS GRANADA, Universidad de Granada. Granada, Spain 36 Nutritional Epidemiology Group, International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008 Lyon, France 22 Public Health Directorate, Asturias, Spain 27 Julius Center for Health Sciences and Primary Care, Cancer Epidemiology University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands 10 Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco (TO), Italy 20 Navarra Institute for Health Research (IdiSNA) Pamplona, Spain 5 Gustave Roussy, F-94805, Villejuif, France 11 Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy 7 Department of Epidemiology, German Inst |
AuthorAffiliation_xml | – name: 20 Navarra Institute for Health Research (IdiSNA) Pamplona, Spain – name: 25 Department of Epidemiology and Biostatistics, MRC-HPA Centre for Environment and Health, School of Public Health, Imperial College London, Norfolk Place W2 1PG London, UK – name: 34 MRC Centre for Transplantation, King’s College London, Great Maze Pond, London SE1 9RT, United Kingdom – name: 17 Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain – name: 10 Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco (TO), Italy – name: 18 Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Institut Català d’Oncologia, Av. Granvia de L’Hospitalet 199-203, 08908 L’Hospitalet de Llobregat, Spain – name: 13 Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy – name: 24 Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands – name: 5 Gustave Roussy, F-94805, Villejuif, France – name: 31 Hellenic Health Foundation, Athens, Greece – name: 30 The Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark – name: 26 Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Pantai Valley, 50603, Kuala Lumpur, Malaysia – name: 16 Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia, Spain – name: 15 Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria, IBS GRANADA, Universidad de Granada. Granada, Spain – name: 23 Department. for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands – name: 29 Department of Public Health, Faculty of Health and Medical Sciences,University of Copenhagen, Denmark – name: 12 Cancer Registry and Histopathology Department, “Civic -M.P.Arezzo” Hospital, ASP Ragusa, Italy – name: 6 Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany – name: 21 Public Health Division of Gipuzkoa, BioDonostia Research Institue, San Sebastian, Spain – name: 1 Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008 Lyon, France – name: 8 Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy – name: 14 CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain – name: 33 Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom – name: 2 Biomarkers Group, International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008 Lyon, France – name: 11 Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy – name: 28 Danish Cancer Society Research Center, Strandboulevarden 49, DK 2100 Copenhagen, Denmark – name: 7 Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, 14558 Nuthetal, Germany – name: 9 Department of Clinical and Biological Sciences, University of Turin, Italy – name: 32 Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, “ATTIKON” University Hospital, Haidari, Greece – name: 19 Navarra Public Health Institute, Pamplona, Spain – name: 22 Public Health Directorate, Asturias, Spain – name: 35 Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece – name: 4 CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, 94805, Villejuif, France – name: 36 Nutritional Epidemiology Group, International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008 Lyon, France – name: 3 Center for Epidemiology and Biostatistics, The University of Melbourne School of Population and Global Health, Parkville, VIC, Australia – name: 27 Julius Center for Health Sciences and Primary Care, Cancer Epidemiology University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands |
Author_xml | – sequence: 1 givenname: Nada orcidid: 0000-0002-0629-3989 surname: Assi fullname: Assi, Nada organization: International Agency for Research on Cancer (IARC) – sequence: 2 givenname: Sabina orcidid: 0000-0002-6846-1204 surname: Rinaldi fullname: Rinaldi, Sabina organization: International Agency for Research on Cancer (IARC) – sequence: 3 givenname: Vivian surname: Viallon fullname: Viallon, Vivian organization: International Agency for Research on Cancer (IARC) – sequence: 4 givenname: S. Ghazaleh orcidid: 0000-0002-1399-7220 surname: Dashti fullname: Dashti, S. Ghazaleh organization: The University of Melbourne School of Population and Global Health – sequence: 5 givenname: Laure surname: Dossus fullname: Dossus, Laure organization: International Agency for Research on Cancer (IARC) – sequence: 6 givenname: Agnès surname: Fournier fullname: Fournier, Agnès organization: International Agency for Research on Cancer (IARC) – sequence: 7 givenname: Iris surname: Cervenka fullname: Cervenka, Iris organization: Gustave Roussy – sequence: 8 givenname: Marina orcidid: 0000-0002-4557-3772 surname: Kvaskoff fullname: Kvaskoff, Marina organization: Gustave Roussy – sequence: 9 givenname: Renée surname: Turzanski‐Fortner fullname: Turzanski‐Fortner, Renée organization: German Cancer Research Center (DKFZ) – sequence: 10 givenname: Manuela surname: Bergmann fullname: Bergmann, Manuela organization: German Institute of Human Nutrition – sequence: 11 givenname: Heiner surname: Boeing fullname: Boeing, Heiner organization: German Institute of Human Nutrition – sequence: 12 givenname: Salvatore surname: Panico fullname: Panico, Salvatore organization: Federico II University – sequence: 13 givenname: Fulvio orcidid: 0000-0001-8749-9737 surname: Ricceri fullname: Ricceri, Fulvio organization: Regional Health Service ASL TO3 – sequence: 14 givenname: Domenico surname: Palli fullname: Palli, Domenico organization: Prevention and Clinical Network – ISPRO – sequence: 15 givenname: Rosario surname: Tumino fullname: Tumino, Rosario organization: “Civic ‐ M.P.Arezzo” Hospital – sequence: 16 givenname: Sara surname: Grioni fullname: Grioni, Sara organization: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano – sequence: 17 givenname: María José surname: Sánchez Pérez fullname: Sánchez Pérez, María José organization: Universidad de Granada – sequence: 18 givenname: María‐Dolores surname: Chirlaque fullname: Chirlaque, María‐Dolores organization: Universidad de Murcia – sequence: 19 givenname: Catalina surname: Bonet fullname: Bonet, Catalina organization: Institut Català d'Oncologia – sequence: 20 givenname: Aurelio Barricarte surname: Gurrea fullname: Gurrea, Aurelio Barricarte organization: Navarra Institute for Health Research (IdiSNA) – sequence: 21 givenname: Pilar surname: Amiano Etxezarreta fullname: Amiano Etxezarreta, Pilar organization: BioDonostia Research Institue – sequence: 22 givenname: Susana surname: Merino fullname: Merino, Susana organization: Public Health Directorate – sequence: 23 givenname: H. Bas surname: Bueno de Mesquita fullname: Bueno de Mesquita, H. Bas organization: University of Malaya – sequence: 24 givenname: Carla H. surname: Gils fullname: Gils, Carla H. organization: Cancer Epidemiology University Medical Center – sequence: 25 givenname: Charlotte surname: Onland‐Moret fullname: Onland‐Moret, Charlotte organization: Cancer Epidemiology University Medical Center – sequence: 26 givenname: Anne surname: Tjønneland fullname: Tjønneland, Anne organization: University of Copenhagen – sequence: 27 givenname: Kim surname: Overvad fullname: Overvad, Kim organization: Aarhus University – sequence: 28 givenname: Antonia surname: Trichopoulou fullname: Trichopoulou, Antonia organization: Hellenic Health Foundation – sequence: 29 givenname: Georgia surname: Martimianaki fullname: Martimianaki, Georgia organization: Hellenic Health Foundation – sequence: 30 givenname: Anna surname: Karakatsani fullname: Karakatsani, Anna organization: National and Kapodistrian University of Athens, “ATTIKON” University Hospital – sequence: 31 givenname: Tim surname: Key fullname: Key, Tim organization: University of Oxford – sequence: 32 givenname: Sofia surname: Christakoudi fullname: Christakoudi, Sofia organization: King's College London – sequence: 33 givenname: Merete surname: Ellingjord‐Dale fullname: Ellingjord‐Dale, Merete organization: School of Public Health, Imperial College London – sequence: 34 givenname: Kostas orcidid: 0000-0002-8452-8472 surname: Tsilidis fullname: Tsilidis, Kostas organization: University of Ioannina School of Medicine – sequence: 35 givenname: Elio surname: Riboli fullname: Riboli, Elio organization: School of Public Health, Imperial College London – sequence: 36 givenname: Rudolf surname: Kaaks fullname: Kaaks, Rudolf organization: German Cancer Research Center (DKFZ) – sequence: 37 givenname: Marc J surname: Gunter fullname: Gunter, Marc J organization: International Agency for Research on Cancer (IARC) – sequence: 38 givenname: Pietro surname: Ferrari fullname: Ferrari, Pietro email: ferrarip@iarc.fr organization: International Agency for Research on Cancer (IARC) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30968961$$D View this record in MEDLINE/PubMed https://hal.science/hal-04424556$$DView record in HAL |
BookMark | eNp9ks9u1DAQxi1URLeFAy-ALHEph7T-kzjJBalaFbpoKzjA2Zo4XuKVYwc7KeyNR-AZeRK8u6WUleBgWfL8vm9mPHOCjpx3GqHnlJxTQtiFWatzzjjLH6EZJXWZEUaLIzRLMZKVlItjdBLjmhBKC5I_Qcec1KKqBZ2h4Ua3BkbjHQYHdhNNxH6Fx05jsMp33v78_mPwcey18wNMESxugoY4YgVO6YCDtjt97MyAmw2O-hvufOhTiREbt7O6-rCY461bGJ-ixyuwUT-7u0_RpzdXH-fX2fL928X8cpmpvCzzTPFcE5ETIkQDq3Sa1J4WgioBQjMioAXWqEq0qm04h4qBBihEK1retI3gp-j13neYml63SrsxgJVDMD2EjfRg5N8RZzr52d9KUVaiJjwZvNobdAey68ul3L6RPGd5UYhbmtizu2TBf5l0HGVvotLWgtN-ipIxUlKR07pK6MsDdO2nkL4-UZwxyouCbQ1fPKz-Pv_vwf2pTgUfY9Cre4QSuV0KmZZC7pYisRcHrDLjbmapcWP_p_hqrN7821ou3s33il9A0spP |
CitedBy_id | crossref_primary_10_3390_ijms25158175 crossref_primary_10_3390_nu13093173 crossref_primary_10_1111_andr_13526 crossref_primary_10_1158_1055_9965_EPI_21_0438 crossref_primary_10_3390_nu14091954 crossref_primary_10_1007_s44197_024_00226_4 crossref_primary_10_1186_s13058_024_01940_4 crossref_primary_10_3390_nu13103582 crossref_primary_10_3390_pathogens12091086 crossref_primary_10_1016_j_ejso_2023_107292 |
Cites_doi | 10.1093/aje/kwq332 10.1111/adb.12589 10.1016/S1470-2045(06)70577-0 10.1079/PHN2002405 10.1002/ijc.11529 10.1093/jnci/93.9.710 10.1158/1055-9965.EPI-12-0310 10.1002/ijc.20694 10.1002/ijc.29469 10.1038/sj.bjc.6600596 10.1007/s10552-006-0041-7 10.1677/erc.1.01038 10.1186/s12885-016-2317-y 10.1111/j.1582-4934.2005.tb00350.x 10.1038/sj.ejcn.1602679 10.1097/EDE.0b013e318258f5e4 10.1186/1475-2891-3-11 10.1186/bcr628 10.1038/bjc.2011.254 10.1210/jc.2004-0614 10.1001/jama.286.17.2143 10.1093/jnci/djn514 10.1093/ije/26.suppl_1.S6 10.1016/S1470-2045(07)70099-2 10.3322/caac.21492 10.1016/S1470-2045(13)70301-2 10.1159/000012789 10.1037/a0031034 10.1177/1010539513488795 10.1158/1940-6207.CAPR-11-0090 10.1016/j.jsbmb.2014.06.001 10.1210/jcem.84.10.6079 10.1093/ije/26.suppl_1.S26 10.1001/jama.2011.1590 10.1079/PHN2002394 10.1016/0895-4356(91)90007-V 10.1016/S1383-5742(03)00016-4 10.1016/j.amepre.2013.10.031 10.1002/ijc.28528 10.1158/1055-9965.EPI-17-0649 10.1093/aje/kwk054 |
ContentType | Journal Article |
Copyright | 2019 UICC 2019 UICC. 2020 UICC Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: 2019 UICC – notice: 2019 UICC. – notice: 2020 UICC – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 1XC VOOES 5PM |
DOI | 10.1002/ijc.32324 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-0215 |
EndPage | 768 |
ExternalDocumentID | PMC6786903 oai_HAL_hal_04424556v1 30968961 10_1002_ijc_32324 IJC32324 |
Genre | article Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
GrantInformation_xml | – fundername: County Council of Skåne – fundername: Ligue Contre le Cancer – fundername: Cancer Research UK funderid: 14136; C570/A16491; C8221/A19170 – fundername: Deutsche Forschungsgemeinschaft funderid: Graduiertenkolleg 793: Epidemiology of communicabl – fundername: Cancerfonden – fundername: National Cancer Institute funderid: 1U01CA98216‐01 – fundername: Regional Government of Navarra – fundername: LK Research Funds – fundername: Health Research Fund (FIS) funderid: PI13/00061 – fundername: Institut National de la Santé et de la Recherche Médicale – fundername: Medical Research Council grantid: G0401527 – fundername: Cancer Research UK grantid: C8221/A19170 – fundername: NCI NIH HHS grantid: 1U01CA98216-01 – fundername: NCI NIH HHS grantid: U01 CA098216 – fundername: Medical Research Council grantid: MR/N003284/1 – fundername: Cancer Research UK grantid: 14136 – fundername: Medical Research Council grantid: 1000143 – fundername: Cancer Research UK grantid: C570/A16491 – fundername: Medical Research Council grantid: MR/M012190/1 – fundername: Medical Research Council grantid: G1000143 |
GroupedDBID | --- -~X .3N .GA 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EMOBN F00 F01 F04 F5P FUBAC G-S G.N GNP GODZA H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RWI RX1 RYL SUPJJ TEORI UB1 UDS V2E V8K V9Y W2D W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR XG1 XPP XV2 ZZTAW ~IA ~WT .55 .GJ .Y3 31~ 3O- 53G 8WZ A6W AANHP AAYXX ABEFU ABEML ACBWZ ACRPL ACSCC ACYXJ ADNMO AEYWJ AGHNM AGQPQ AGYGG AHEFC AI. ASPBG AVWKF AZFZN BDRZF CITATION EJD EX3 FEDTE GLUZI HF~ HVGLF LW6 M6P PALCI RJQFR SAMSI VH1 WOW X7M Y6R ZGI ZXP AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7T5 7TO 7U9 H94 K9. 7X8 1XC VOOES 5PM |
ID | FETCH-LOGICAL-c4774-c34e0640066baf6bab324e661c6a6e206ada2bc86dcdb33a82aeaa56d6d3bdb63 |
IEDL.DBID | DR2 |
ISSN | 0020-7136 1097-0215 |
IngestDate | Thu Aug 21 14:19:18 EDT 2025 Fri May 09 12:15:48 EDT 2025 Fri Jul 11 05:24:59 EDT 2025 Fri Jul 25 09:29:31 EDT 2025 Mon Jul 21 06:02:40 EDT 2025 Tue Jul 01 02:28:28 EDT 2025 Thu Apr 24 22:50:45 EDT 2025 Wed Jan 22 16:41:02 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | alcohol sex steroids breast cancer mediation analysis EPIC hormonal signature |
Language | English |
License | 2019 UICC. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4774-c34e0640066baf6bab324e661c6a6e206ada2bc86dcdb33a82aeaa56d6d3bdb63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-6846-1204 0000-0001-8749-9737 0000-0002-0629-3989 0000-0002-8452-8472 0000-0002-1399-7220 0000-0002-4557-3772 0000-0001-8380-3439 0000-0002-5558-2437 0000-0002-3275-2026 |
OpenAccessLink | https://hal.science/hal-04424556 |
PMID | 30968961 |
PQID | 2322135521 |
PQPubID | 105430 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6786903 hal_primary_oai_HAL_hal_04424556v1 proquest_miscellaneous_2207164198 proquest_journals_2322135521 pubmed_primary_30968961 crossref_primary_10_1002_ijc_32324 crossref_citationtrail_10_1002_ijc_32324 wiley_primary_10_1002_ijc_32324_IJC32324 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 1 February 2020 |
PublicationDateYYYYMMDD | 2020-02-01 |
PublicationDate_xml | – month: 02 year: 2020 text: 1 February 2020 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Hoboken |
PublicationTitle | International journal of cancer |
PublicationTitleAlternate | Int J Cancer |
PublicationYear | 2020 |
Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc Wiley |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc – name: Wiley |
References | 2001; 286 2001; 93 2013; 25 2002; 94 2005; 90 1997; 26 2002; 5 2007; 165 2005; 114 2006; 17 2015; 145 2015; 30 2017; 24 2002; 11 2006; 7 1998 2004; 3 2014; 46 1999; 43 1999; 84 2003 2011; 4 2004; 108 2016; 16 2018; 27 2014; 137 2018; 68 2011; 105 2013; 18 2011; 306 2013; 14 2015; 137 1991; 44 2005; 9 2002; 87 2007; 8 2018 2009; 101 2003; 5 2010; 172 2007; 61 2015 2003; 544 2012; 23 2012; 21 2005; 12 e_1_2_9_50_1 e_1_2_9_12_1 Ferlay J (e_1_2_9_3_1) 2018 Assi N (e_1_2_9_35_1) 2015; 30 Rinaldi S (e_1_2_9_31_1) 2002; 11 e_1_2_9_14_1 e_1_2_9_39_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_18_1 e_1_2_9_20_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_24_1 e_1_2_9_43_1 e_1_2_9_8_1 e_1_2_9_6_1 e_1_2_9_4_1 e_1_2_9_2_1 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_28_1 e_1_2_9_47_1 e_1_2_9_30_1 Vanderweele TJ (e_1_2_9_38_1) 2015 e_1_2_9_51_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_13_1 e_1_2_9_32_1 Kufe DW (e_1_2_9_41_1) 2003 World Cancer Research Fund/American Institute for Cancer Research (e_1_2_9_10_1) 2018 The Endogenous Hormones and Breast Cancer Collaborative Group (e_1_2_9_19_1) 2002; 94 e_1_2_9_15_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_42_1 e_1_2_9_40_1 e_1_2_9_21_1 e_1_2_9_46_1 e_1_2_9_23_1 e_1_2_9_44_1 e_1_2_9_7_1 e_1_2_9_5_1 Tenenhaus M (e_1_2_9_33_1) 1998 e_1_2_9_9_1 e_1_2_9_25_1 e_1_2_9_27_1 e_1_2_9_48_1 e_1_2_9_29_1 |
References_xml | – volume: 94 start-page: 606 year: 2002 end-page: 16 article-title: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies publication-title: Cancer Spectrum Knowl Environ – volume: 16 start-page: 283 year: 2016 article-title: Alcohol‐related breast cancer in postmenopausal women – effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex‐hormone levels and interaction with alcohol consumption and NSAID usage in a nested case‐control study and a randomised controlled tr publication-title: BMC Cancer – start-page: 728 year: 2015 – volume: 5 start-page: 239 year: 2003 end-page: 47 article-title: Oestrogen exposure and breast cancer risk publication-title: Breast Cancer Res – volume: 87 start-page: 1234 year: 2002 end-page: 45 article-title: Alcohol, tobacco and breast cancer—collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease publication-title: Br J Cancer – volume: 137 start-page: 1921 year: 2015 end-page: 30 article-title: Alcohol intake and breast cancer in the European prospective investigation into cancer and nutrition publication-title: Int J Cancer – volume: 84 start-page: 3666 year: 1999 end-page: 72 article-title: Critical evaluation of simple methods for the estimation of free testosterone in serum publication-title: J Clin Endocrinol Metab – volume: 44 start-page: 1055 year: 1991 end-page: 61 article-title: Repeated serum and urinary androgen measurements in premenopausal and postmenopausal women publication-title: J Clin Epidemiol – volume: 286 start-page: 2143 year: 2001 article-title: Alcohol and breast cancer publication-title: JAMA – volume: 3 start-page: 11 year: 2004 article-title: The effects of moderate alcohol supplementation on estrone sulfate and DHEAS in postmenopausal women in a controlled feeding study publication-title: Nutr J – volume: 14 start-page: 1009 year: 2013 end-page: 19 article-title: Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies publication-title: Lancet Oncol – volume: 137 start-page: 1947 year: 2014 end-page: 57 article-title: Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status—results from the EPIC cohort publication-title: Int J Cancer – volume: 93 start-page: 710 year: 2001 end-page: 5 article-title: Serum hormones and the alcohol‐breast cancer association in postmenopausal women publication-title: J Natl Cancer Inst – year: 2018 – volume: 8 start-page: 292 year: 2007 end-page: 3 article-title: WHO International Agency for Research on Cancer monograph working group. Carcinogenicity of alcoholic beverages publication-title: Lancet Oncol – volume: 24 start-page: 157 year: 2017 end-page: 69 article-title: Sex hormones in alcohol consumption: a systematic review of evidence publication-title: Addict Biol – volume: 4 start-page: 1626 year: 2011 end-page: 36 article-title: Postmenopausal serum sex steroids and risk of hormone receptor‐positive and ‐negative breast cancer: a nested case–control study publication-title: Cancer Prev Res – year: 1998 – volume: 5 start-page: 1287 year: 2002 end-page: 96 article-title: Patterns of alcohol consumption in 10 European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) project publication-title: Public Health Nutr – volume: 68 start-page: 394 year: 2018 end-page: 424 article-title: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 21 start-page: 1203 year: 2012 end-page: 12 article-title: Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer publication-title: Cancer Epidemiol Biomarkers Prev – volume: 18 start-page: 137 year: 2013 end-page: 50 article-title: Mediation analysis allowing for exposure‐mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros publication-title: Psychol Methods – volume: 30 start-page: 743 year: 2015 end-page: 53 article-title: A statistical framework to model the meeting‐in‐the‐middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study publication-title: Mutagenesis – volume: 61 start-page: 1037 year: 2007 end-page: 56 article-title: The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study publication-title: Eur J Clin Nutr – volume: 5 start-page: 1113 year: 2002 end-page: 24 article-title: European prospective investigation into cancer and nutrition (EPIC): study populations and data collection publication-title: Public Health Nutr – volume: 172 start-page: 1339 year: 2010 end-page: 48 article-title: Odds ratios for mediation analysis for a dichotomous outcome publication-title: Am J Epidemiol – volume: 23 start-page: 561 year: 2012 end-page: 4 article-title: The role of measurement error and misclassification in mediation analysis: mediation and measurement error publication-title: Epidemiology – volume: 105 start-page: 709 year: 2011 end-page: 22 article-title: Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies publication-title: Br J Cancer – volume: 7 start-page: 149 year: 2006 end-page: 56 article-title: Alcohol and cancer publication-title: Lancet Oncol – volume: 12 start-page: 1071 year: 2005 end-page: 82 article-title: Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition publication-title: Endocr Relat Cancer – volume: 114 start-page: 323 year: 2005 end-page: 7 article-title: Postmenopausal levels of sex hormones and risk of breast carcinoma in situ: results of a prospective study publication-title: Int J Cancer – volume: 306 start-page: 1884 year: 2011 end-page: 90 article-title: Moderate alcohol consumption during adult life, drining patterns, and breast cancer publication-title: JAMA – volume: 90 start-page: 1414 year: 2005 end-page: 9 article-title: Alcohol and endogenous sex steroid levels in postmenopausal women: a cross‐sectional study publication-title: J Clin Endocrinol Metab – volume: 17 start-page: 1033 year: 2006 end-page: 43 article-title: Relationship of alcohol intake and sex steroid concentrations in blood in pre‐ and post‐menopausal women : the European prospective investigation into cancer and nutrition publication-title: Cancer Causes Control – volume: 43 start-page: 225 year: 1999 end-page: 34 article-title: Follow‐up procedures in EPIC‐Germany—data quality aspects publication-title: Ann Nutr Metab – volume: 46 start-page: S16 year: 2014 end-page: 25 article-title: Female breast cancer and alcohol consumption publication-title: Am J Prev Med – year: 2003 – volume: 11 start-page: 1065 year: 2002 end-page: 71 article-title: Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations publication-title: Cancer Epidemiol Biomarkers Prev – volume: 26 start-page: S6 issue: Suppl 1 year: 1997 end-page: 14 article-title: The EPIC project: rationale and study design. European prospective investigation into cancer and nutrition publication-title: Int J Epidemiol – volume: 26 start-page: 26 year: 1997 end-page: 36 article-title: Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results publication-title: Int J Epidemiol – volume: 108 start-page: 425 year: 2004 end-page: 32 article-title: Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women publication-title: Int J Cancer – volume: 145 start-page: 133 year: 2015 end-page: 8 article-title: All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause publication-title: J Steroid Biochem Mol Biol – volume: 9 start-page: 208 year: 2005 end-page: 21 article-title: Understanding breast cancer risk—where do we stand in 2005? publication-title: J Cell Mol Med – volume: 544 start-page: 9 year: 2003 end-page: 41 article-title: Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism publication-title: Mutat Res – volume: 165 start-page: 667 year: 2007 end-page: 76 article-title: Alcohol consumption and breast cancer risk in the Women's health study publication-title: Am J Epidemiol – volume: 101 start-page: 296 year: 2009 end-page: 305 article-title: Moderate alcohol intake and cancer incidence in women publication-title: J Natl Cancer Inst – volume: 87 start-page: 1234 year: 2002 end-page: 45 article-title: Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Collaborative group on hormonal factors in breast cancer publication-title: Br J Cancer – volume: 27 start-page: 531 year: 2018 end-page: 40 article-title: Are metabolic signatures mediating the relationship between lifestyle factors and hepatocellular carcinoma risk? Results from a nested case‐control study in EPIC publication-title: Cancer Epidemiol Biomarkers Prev – volume: 25 start-page: 368 year: 2013 end-page: 87 article-title: Risk factors of breast cancer: a systematic review and meta‐analysis publication-title: Asia Pac J Public Health – start-page: 728 volume-title: Explanation in causal inference: methods for mediation and interaction year: 2015 ident: e_1_2_9_38_1 – ident: e_1_2_9_37_1 doi: 10.1093/aje/kwq332 – ident: e_1_2_9_14_1 doi: 10.1111/adb.12589 – ident: e_1_2_9_9_1 doi: 10.1016/S1470-2045(06)70577-0 – ident: e_1_2_9_26_1 doi: 10.1079/PHN2002405 – ident: e_1_2_9_50_1 doi: 10.1002/ijc.11529 – ident: e_1_2_9_46_1 doi: 10.1093/jnci/93.9.710 – ident: e_1_2_9_22_1 doi: 10.1158/1055-9965.EPI-12-0310 – ident: e_1_2_9_48_1 doi: 10.1002/ijc.20694 – volume: 94 start-page: 606 year: 2002 ident: e_1_2_9_19_1 article-title: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies publication-title: Cancer Spectrum Knowl Environ – ident: e_1_2_9_11_1 doi: 10.1002/ijc.29469 – ident: e_1_2_9_40_1 doi: 10.1038/sj.bjc.6600596 – ident: e_1_2_9_20_1 doi: 10.1007/s10552-006-0041-7 – ident: e_1_2_9_28_1 doi: 10.1677/erc.1.01038 – ident: e_1_2_9_47_1 doi: 10.1186/s12885-016-2317-y – ident: e_1_2_9_42_1 doi: 10.1111/j.1582-4934.2005.tb00350.x – ident: e_1_2_9_27_1 doi: 10.1038/sj.ejcn.1602679 – ident: e_1_2_9_51_1 doi: 10.1097/EDE.0b013e318258f5e4 – ident: e_1_2_9_45_1 doi: 10.1186/1475-2891-3-11 – volume-title: La régression PLS year: 1998 ident: e_1_2_9_33_1 – ident: e_1_2_9_16_1 doi: 10.1186/bcr628 – ident: e_1_2_9_18_1 doi: 10.1038/bjc.2011.254 – ident: e_1_2_9_15_1 doi: 10.1210/jc.2004-0614 – ident: e_1_2_9_44_1 doi: 10.1001/jama.286.17.2143 – ident: e_1_2_9_7_1 doi: 10.1093/jnci/djn514 – ident: e_1_2_9_23_1 doi: 10.1093/ije/26.suppl_1.S6 – volume: 30 start-page: 743 year: 2015 ident: e_1_2_9_35_1 article-title: A statistical framework to model the meeting‐in‐the‐middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study publication-title: Mutagenesis – volume-title: Diet, nutrition, physical activity and cancer: a global perspective a summary of the third expert report year: 2018 ident: e_1_2_9_10_1 – ident: e_1_2_9_5_1 doi: 10.1016/S1470-2045(07)70099-2 – ident: e_1_2_9_2_1 doi: 10.3322/caac.21492 – ident: e_1_2_9_13_1 doi: 10.1016/S1470-2045(13)70301-2 – ident: e_1_2_9_30_1 doi: 10.1159/000012789 – volume-title: Global cancer observatory: cancer tomorrow year: 2018 ident: e_1_2_9_3_1 – ident: e_1_2_9_36_1 doi: 10.1037/a0031034 – ident: e_1_2_9_4_1 doi: 10.1177/1010539513488795 – ident: e_1_2_9_29_1 doi: 10.1158/1940-6207.CAPR-11-0090 – ident: e_1_2_9_21_1 doi: 10.1016/j.jsbmb.2014.06.001 – ident: e_1_2_9_32_1 doi: 10.1210/jcem.84.10.6079 – ident: e_1_2_9_25_1 doi: 10.1093/ije/26.suppl_1.S26 – volume: 11 start-page: 1065 year: 2002 ident: e_1_2_9_31_1 article-title: Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations publication-title: Cancer Epidemiol Biomarkers Prev – ident: e_1_2_9_8_1 doi: 10.1001/jama.2011.1590 – ident: e_1_2_9_24_1 doi: 10.1079/PHN2002394 – ident: e_1_2_9_49_1 doi: 10.1016/0895-4356(91)90007-V – volume-title: Holland‐Frei Cancer medicine year: 2003 ident: e_1_2_9_41_1 – ident: e_1_2_9_43_1 doi: 10.1016/S1383-5742(03)00016-4 – ident: e_1_2_9_12_1 doi: 10.1016/j.amepre.2013.10.031 – ident: e_1_2_9_6_1 doi: 10.1038/sj.bjc.6600596 – ident: e_1_2_9_17_1 doi: 10.1002/ijc.28528 – ident: e_1_2_9_34_1 doi: 10.1158/1055-9965.EPI-17-0649 – ident: e_1_2_9_39_1 doi: 10.1093/aje/kwk054 |
SSID | ssj0011504 |
Score | 2.413906 |
Snippet | Alcohol consumption is associated with higher risk of breast cancer (BC); however, the biological mechanisms underlying this association are not fully... |
SourceID | pubmedcentral hal proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 759 |
SubjectTerms | 17β-Estradiol Aged alcohol Alcohol Drinking - adverse effects Alcohol Drinking - blood Alcohol Drinking - epidemiology Alcohol use Breast cancer Breast Neoplasms - epidemiology Breast Neoplasms - etiology Cancer Case-Control Studies EPIC Estradiol - blood Female Globulins hormonal signature Hormone replacement therapy Humans Incidence Life Sciences Mediation mediation analysis Medical research Middle Aged Post-menopause Postmenopause - blood Prospective Studies Sex Hormone-Binding Globulin - analysis Sex hormones sex steroids Statistical analysis Steroid hormones Testosterone Testosterone - blood Tumors |
Title | Mediation analysis of the alcohol‐postmenopausal breast cancer relationship by sex hormones in the EPIC cohort |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.32324 https://www.ncbi.nlm.nih.gov/pubmed/30968961 https://www.proquest.com/docview/2322135521 https://www.proquest.com/docview/2207164198 https://hal.science/hal-04424556 https://pubmed.ncbi.nlm.nih.gov/PMC6786903 |
Volume | 146 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VHhAXKO-FFhnEgUu2iR07WXGqVq22FYsQolIPSJHtONotKLvaZBFw6k_ob-SXdMZ5wFKQEIdIUfxI7MzY32Qm3wC8TGRSxDoNg6TgDg2UXBLlrQusFpHikSlCR_87T9-qyWl8cibPtuB19y9Mww_Rf3AjzfDrNSm4NtX-T9LQ-bkdCsIDuP5SrBYBovc9dRQBnZaBGZ8jIhflTtt2v2-5sRfdmFEk5HWYeT1a8lcU67ehozvwsRtAE33yabiuzdB-_43b8T9HuAO3W3jKDhp5ugtbrrwHN6etA_4-LKc-tQe-TKZbOhO2KBiiSKabZLs_Li6Xi4pi19EcX1fYmaG495pZkq8VW3XRd7P5kplvrHJf2QyBM-UMYPPSd3X47njMqLdV_QBOjw4_jCdBm7QhsDFCycCK2JF3EKGM0QUeBgfgEAVYpZXjodK55samKre5EUKnXDutpcpVLkxulHgI2yXe8jEwK0bK4poRp0SnbiItcSdNCikSgUablAN41b2-zLaM5pRY43PWcDHzDGcw8zM4gBd91WVD4_HHSigDfTkRb08O3mR0LYzJQyzVl2gAu52IZK26Vxm25hEiN47Fz_tiVFTyvujSLdZYh4dkm0ajdACPGonqbyXQkExHClsnG7K28SybJeV85snAEWyoUShwLrwo_X102fHJ2J88-feqT-EWJwXyUeq7sF2v1m4PQVhtnnltuwJBzC6G |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB61RQIuUB6F0AIL4sDFqb1rrx2JSxW1SkpSIdRKvSBrd71WAsiJEgcBp_6E_sb-EmbWDwgFCXGwZHlf3vWM9xvP-BuAV3EU56FKfC_OuUUDJYuI8tZ6RolA8kDnvqX_nccncnAWHp9H5xvwpvkXpuKHaD-4kWa49zUpOH2Q3v_JGjr9aLqCAMEm3KCM3s6get-SRxHUqTmY8U4CclJu143326Zru9HmhGIhrwPN6_GSv-JYtxEd3YUPzRSq-JNP3VWpu-b7b-yO_zvHbbhTI1R2UInUPdiwxX24Oa598A9gPnbZPfB5MlUzmrBZzhBIMlXl2726uJzPlhS-jhb5aomdaQp9L5khEVuwRROAN5nOmf7GlvYrmyB2prQBbFq4rg7fDfuMeluUD-Hs6PC0P_DqvA2eCRFNekaElhyEiGa0yvHQOAGLQMBIJS33pcoU1yaRmcm0ECrhyioVyUxmQmdaih3YKnDIx8CM6EmDr40wIUZ1HagIN9M4j0Qs0G6Log68bp5fampSc8qt8Tmt6Jh5iiuYuhXswMu26rxi8vhjJRSCtpy4twcHo5Su-SE5iSP5JejAXiMjaa3xyxRb8wDBG8fiF20x6io5YFRhZyusw30yT4Ne0oFHlUi1Qwm0JZOexNbxmrCt3ct6STGdOD5wxBuy5wtcCydLf59dOjzuu5Mn_171OdwanI5H6Wh48nYXbnPSJhe0vgdb5WJlnyImK_Uzp3o_AAJUMqE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB61Raq4lPIqgQIL4sAlqb1rrx1xqtJGSWmqClGpByRrd71WQpFjJQ4CTvwEfiO_hJn1A0JBQhwsWd6Xdz3j_cYz_gbgRRRGWaBirxtl3KKBkoZEeWu7Rglfcl9nnqX_nSdncnQRnFyGlxvwqvkXpuKHaD-4kWa49zUpeJFmBz9JQ2fvTU8QHtiEG4H0YhLpozctdxQhnZqCGW_EJx_lbt34oG26thltTikU8jrOvB4u-SuMdfvQ8Ba8a2ZQhZ9c9Val7pkvv5E7_ucUd2GnxqfssBKo27Bh8zuwPak98HehmLjcHvg0mar5TNg8Ywgjmaqy7X7_-q2YLyl4He3x1RI70xT4XjJDArZgiyb8bjormP7MlvYTmyJypqQBbJa7ro7PxwNGvS3Ke3AxPH47GHXrrA1dEyCW7BoRWHIPIpbRKsND4wQswgAjlbTckypVXJtYpibVQqiYK6tUKFOZCp1qKe7DVo5DPgBmRF8afGkEMfGpa1-FuJVGWSgigVZbGHbgZfP4ElNTmlNmjQ9JRcbME1zBxK1gB563VYuKx-OPlVAG2nJi3h4dniZ0zQvIRRzKj34H9hsRSWp9XybYmvsI3TgWP2uLUVPJ_aJyO19hHe6Rcer34w7sVRLVDiXQkoz7EltHa7K2di_rJfls6tjAEW3IvidwLZwo_X12yfhk4E4e_nvVp7B9fjRMTsdnrx_BTU665CLW92GrXKzsYwRkpX7iFO8Ha2sxWQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mediation+analysis+of+the+alcohol%E2%80%90postmenopausal+breast+cancer+relationship+by+sex+hormones+in+the+EPIC+cohort&rft.jtitle=International+journal+of+cancer&rft.au=Assi%2C+Nada&rft.au=Rinaldi%2C+Sabina&rft.au=Viallon%2C+Vivian&rft.au=S+Ghazaleh+Dashti&rft.date=2020-02-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=146&rft.issue=3&rft.spage=759&rft.epage=768&rft_id=info:doi/10.1002%2Fijc.32324&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon |